Follow-up·July 7, 2021

Donna Gurriere, Licensing Program Analyst (LPA) arrived at the facility unannounced to conduct a case management visit. LPA Gurriere met with Pamela Eiszele, Administrator and advised of the purpose of the inspection. LPA Gurriere completed the required COVID-19 testing protocols, and a daily self- screening questionnaire for symptoms of COVID 19 infection to affirm no COVID-19 related symptoms. The administrator was contacted to complete a facility risk assessment. LPA Gurriere ensured that hand sanitizer was applied before entering the facility and the following Personal Protective Equipment (PPE) was worn: N-95 mask. Additionally, LPA was screened by the receptionist upon entering the facility. During the month of June 2021, it was reported that a resident’s (Resident 1) medications were not accurate. The purpose of this visit is to review a resident’s medications and ensure that the facility is following the physician’s medication orders for the resident. The resident was interviewed and advised that in March 2021 his physician lowered a dosage amount of a medication that he was taking. The resident has requested that the administrator talk to his physician to see if the medication can be increased to assist with a side effect that he is experiencing. The administrator has agreed to speak with the resident's physician to ask if the physician can re-review the resident's medication. The facility staff are currently following the physician's orders of the prescribed medication. During today's visit the administrator scheduled a visit for the resident to see his physician. An exit interview was conducted, and a copy of the report was given to the administrator .